Based on single‐cell transcriptomics and untargeted metabolomic sequencing analysis of mice with NAFLD and renal fibrosis, we predicted that the liver excretory protein ANGPTL8 acts as a bridge in the progression of kidney fibrosis exacerbated by NAFLD. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.